Imigran 50 mg tablete
| Name | Imigran 50 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-584958851 |
| Active Substance | sumatriptansukcinat |
| Composition | jedna tableta sadržava 50 mg sumatriptana u obliku sumatriptansukcinata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Delpharm Poznan S.A., Poznanj, Poljska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/538 |
| Registration Number | 381-12-01/70-21-24 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N02CC01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
